These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34692687)

  • 1. HMG-Coenzyme A Reductase as a Drug Target for the Prevention of Ankylosing Spondylitis.
    Zhong Z; Feng X; Su G; Du L; Liao W; Liu S; Li F; Zuo X; Yang P
    Front Cell Dev Biol; 2021; 9():731072. PubMed ID: 34692687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of genetically proxied inhibition of HMG-CoA reductase, NPC1L1, and PCSK9 with breast cancer and prostate cancer.
    Sun L; Ding H; Jia Y; Shi M; Guo D; Yang P; Wang Y; Liu F; Zhang Y; Zhu Z
    Breast Cancer Res; 2022 Feb; 24(1):12. PubMed ID: 35151363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Genetically Proxied Inhibition of HMG-CoA Reductase and Epithelial Ovarian Cancer.
    Yarmolinsky J; Bull CJ; Vincent EE; Robinson J; Walther A; Smith GD; Lewis SJ; Relton CL; Martin RM
    JAMA; 2020 Feb; 323(7):646-655. PubMed ID: 32068819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using genetic variants to evaluate the causal effect of cholesterol lowering on head and neck cancer risk: A Mendelian randomization study.
    Gormley M; Yarmolinsky J; Dudding T; Burrows K; Martin RM; Thomas S; Tyrrell J; Brennan P; Pring M; Boccia S; Olshan AF; Diergaarde B; Hung RJ; Liu G; Legge D; Tajara EH; Severino P; Lacko M; Ness AR; Davey Smith G; Vincent EE; Richmond RC
    PLoS Genet; 2021 Apr; 17(4):e1009525. PubMed ID: 33886544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Common and Rare Genetic Variation in the 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Gene and Cataract Risk.
    Ghouse J; Ahlberg G; Skov AG; Bundgaard H; Olesen MS
    J Am Heart Assoc; 2022 Jun; 11(12):e025361. PubMed ID: 35703387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study.
    Fang S; Yarmolinsky J; Gill D; Bull CJ; Perks CM; ; Davey Smith G; Gaunt TR; Richardson TG
    PLoS Med; 2023 Jan; 20(1):e1003988. PubMed ID: 36595504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between Genetically Proxied Inhibition of Lipid-Lowering Drug Targets and Serum Micronutrients among Individuals of European Descent: A Mendelian Randomization Study.
    He JY; Zhang X; Wang K; Lv WQ
    J Nutr; 2022 May; 152(5):1283-1290. PubMed ID: 35349717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both: a 2 × 2 factorial Mendelian randomization study.
    Ference BA; Majeed F; Penumetcha R; Flack JM; Brook RD
    J Am Coll Cardiol; 2015 Apr; 65(15):1552-61. PubMed ID: 25770315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype-driven NPC1L1 and PCSK9 inhibition and reduced risk of periodontitis.
    Baumeister SE; Holtfreter B; Reckelkamm SL; Kocher T; Alayash Z; Ehmke B; Baurecht H; Nolde M
    J Clin Periodontol; 2023 Jan; 50(1):114-120. PubMed ID: 36054135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes.
    Ference BA; Robinson JG; Brook RD; Catapano AL; Chapman MJ; Neff DR; Voros S; Giugliano RP; Davey Smith G; Fazio S; Sabatine MS
    N Engl J Med; 2016 Dec; 375(22):2144-2153. PubMed ID: 27959767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential associations of statin treatment and polymorphism in genes coding for HMGCR and PCSK9 to risk for insomnia.
    Alsehli AM; Rukh G; Clemensson LE; Ciuculete DM; Tan X; Al-Sabri MH; Williams MJ; Benedict C; Schiöth HB
    Front Biosci (Landmark Ed); 2021 Dec; 26(12):1453-1463. PubMed ID: 34994160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between genetically proxied HMGCR inhibition and male reproductive health: A Mendelian randomization study.
    Yan Z; Xu Y; Li K; Liu L
    Medicine (Baltimore); 2023 Sep; 102(39):e34690. PubMed ID: 37773823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can Lipid-Lowering Drugs Reduce the Risk of Cholelithiasis? A Mendelian Randomization Study.
    Dong H; Chen R; Xu F; Cheng F
    Clin Epidemiol; 2024; 16():131-141. PubMed ID: 38410417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Genetically Proxied Lipid-Lowering Drug Targets and Renal Cell Carcinoma: A Mendelian Randomization Study.
    Liu L; Sheng C; Lyu Z; Dai H; Chen K
    Front Nutr; 2021; 8():755834. PubMed ID: 34712689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between Genetically Proxied Inhibition of HMG-CoA Reductase and Age at Onset of Huntington's Disease.
    Zhu Y; Li M; Wang H; Yang F; Wang J; Huang X
    Brain Sci; 2022 Nov; 12(11):. PubMed ID: 36421875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein signatures of cholesteryl ester transfer protein and HMG-CoA reductase inhibition.
    Kettunen J; Holmes MV; Allara E; Anufrieva O; Ohukainen P; Oliver-Williams C; Wang Q; Tillin T; Hughes AD; Kähönen M; Lehtimäki T; Viikari J; Raitakari OT; Salomaa V; Järvelin MR; Perola M; Davey Smith G; Chaturvedi N; Danesh J; Di Angelantonio E; Butterworth AS; Ala-Korpela M
    PLoS Biol; 2019 Dec; 17(12):e3000572. PubMed ID: 31860674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-density lipoprotein cholesterol and lifespan: A Mendelian randomization study.
    Daghlas I; Gill D
    Br J Clin Pharmacol; 2021 Oct; 87(10):3916-3924. PubMed ID: 33704808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low LDL cholesterol,
    Benn M; Nordestgaard BG; Frikke-Schmidt R; Tybjærg-Hansen A
    BMJ; 2017 Apr; 357():j1648. PubMed ID: 28438747
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic variations in HMGCR and PCSK9 and kidney function: a Mendelian randomization study.
    Park S; Kim SG; Lee S; Kim Y; Cho S; Kim K; Kim YC; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK
    Kidney Res Clin Pract; 2023 Jul; 42(4):460-472. PubMed ID: 37448291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of NPC1L1 and HMGCR gene polymorphisms with coronary artery calcification in patients with premature triple-vessel coronary disease.
    Li Y; Li J; Tang X; Xu J; Liu R; Jiang L; Tian J; Zhang Y; Wang D; Sun K; Xu B; Zhao W; Hui R; Gao R; Song L; Yuan J; Zhao X
    BMC Med Genomics; 2024 Jan; 17(1):22. PubMed ID: 38233830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.